Search
Matinas BioPharma Holdings Inc
MTNBAdd to Watchlist
0.665USD
+0.001+0.09%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
3.92MMarket Cap
LossP/E TTM
Matinas BioPharma Holdings Inc's Company Valuation
Currency: USD Updated: 2026-06-30The current valuation score of Matinas BioPharma Holdings Inc is 7.88, ranking 181 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.31, which is -100.00% below the recent high of 0.00 and -2340.73% above the recent low of -7.56.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
